ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AMRN Amarin Corp PLC

1.19
0.00 (0.00%)
Pre Market
Last Updated: 04:38:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3
Bid Price 1.16
Ask Price 1.23
News -
Share Name Share Symbol Market Stock Type
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.19 04:38:06
Open Price Low Price High Price Close Price Previous Close
1.19
Trades Shares Traded Average Volume
1 3 -
Last Trade Type Quantity Price Currency
03:00:04 3  1.19 USD

Amarin Corp PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 369.19M -105.8M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Amarin

Date Time Source Heading
2/15/202407:00GlobeNewswire Inc.Amarin to Report Fourth Quarter and Full Year 2023 Financial..
2/12/202407:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
2/09/202415:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/09/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/09/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/26/202406:00Edgar (US Regulatory)Form 8-K - Current report
1/24/202415:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/22/202406:30GlobeNewswire Inc.Amarin Chairman & CEO Issue Letter to Shareholders
1/12/202416:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMRN Message Board. Create One! See More Posts on AMRN Message Board See More Message Board Posts

AMRN Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com